Giuseppe Curigliano: Benefit of Extended ET With OFS in Premenopausal Node-Positive eBC

Giuseppe Curigliano, President Elect of ESMO and Member of the Editorial Board at OncoDaily, shared a post on X:

“Extending ET with OFS in premenopausal patients with node-positive eBC after 5 years of LHRHa treatment is associated with a clinically meaningful reduction in both invasive and distant breast cancer recurrences.”